PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $394,954 | -43.9% | 17,624 | +1.9% | 0.00% | – |
| Q2 2023 | $703,632 | -18.7% | 17,301 | -3.1% | 0.00% | -100.0% |
| Q1 2023 | $864,993 | +25.4% | 17,857 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $689,694 | -22.2% | 18,069 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $887,000 | +29.1% | 17,672 | +3.1% | 0.00% | 0.0% |
| Q2 2022 | $687,000 | -11.6% | 17,143 | -17.7% | 0.00% | – |
| Q1 2022 | $777,000 | -3.7% | 20,818 | +2.7% | 0.00% | – |
| Q4 2021 | $807,000 | -25.1% | 20,275 | -29.9% | 0.00% | -100.0% |
| Q3 2021 | $1,077,000 | -6.8% | 28,935 | +5.8% | 0.00% | 0.0% |
| Q2 2021 | $1,155,000 | -13.5% | 27,339 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $1,336,000 | -26.1% | 28,229 | -4.7% | 0.00% | 0.0% |
| Q4 2020 | $1,809,000 | +72.8% | 29,633 | +32.2% | 0.00% | 0.0% |
| Q3 2020 | $1,047,000 | -12.4% | 22,407 | -4.9% | 0.00% | 0.0% |
| Q2 2020 | $1,195,000 | +60.0% | 23,552 | +40.6% | 0.00% | 0.0% |
| Q1 2020 | $747,000 | -3.2% | 16,752 | +4.1% | 0.00% | 0.0% |
| Q4 2019 | $772,000 | +29.5% | 16,086 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $596,000 | -17.0% | 17,610 | +10.2% | 0.00% | 0.0% |
| Q2 2019 | $718,000 | -56.4% | 15,973 | -63.4% | 0.00% | -50.0% |
| Q1 2019 | $1,645,000 | +13.2% | 43,698 | +3.2% | 0.00% | 0.0% |
| Q4 2018 | $1,453,000 | -22.7% | 42,331 | +5.8% | 0.00% | 0.0% |
| Q3 2018 | $1,880,000 | +52.1% | 40,000 | +9.2% | 0.00% | +100.0% |
| Q2 2018 | $1,236,000 | +62.2% | 36,646 | +30.1% | 0.00% | 0.0% |
| Q1 2018 | $762,000 | +86.8% | 28,171 | +15.1% | 0.00% | – |
| Q4 2017 | $408,000 | +45.2% | 24,467 | +319.2% | 0.00% | – |
| Q2 2015 | $281,000 | +18.1% | 5,836 | +49.0% | 0.00% | – |
| Q1 2015 | $238,000 | +16.1% | 3,916 | -1.3% | 0.00% | – |
| Q4 2014 | $205,000 | – | 3,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |